Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_assertion type Assertion NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_head.
- NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_assertion description "[CEA, TPA, SCC-Ag, CYFRA 21-1, ferritin, CA19-9, CA50, CA242, H-K-N-ras mutations and p53 mutation seem to be the most prolific in NSCLC, while NSE, BN/GRP, CK-BB, NCAM, IL-2R, IGF-I, transferrin, ANP, mAb (cluster 5), Le-y and c-N-L-myc mutation are markers in SCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_provenance.
- NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_assertion evidence source_evidence_literature NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_provenance.
- NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_assertion SIO_000772 7539317 NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_provenance.
- NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_assertion wasDerivedFrom befree-2016 NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_provenance.
- NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_assertion wasGeneratedBy ECO_0000203 NP1311467.RAqFYu6mzWjLXc8gwS0iH_62yUwxicGbVoaY94SeX3o4U130_provenance.